SI0858325T1 - Stable freeze-dried pharmaceutical formulation - Google Patents

Stable freeze-dried pharmaceutical formulation

Info

Publication number
SI0858325T1
SI0858325T1 SI9630529T SI9630529T SI0858325T1 SI 0858325 T1 SI0858325 T1 SI 0858325T1 SI 9630529 T SI9630529 T SI 9630529T SI 9630529 T SI9630529 T SI 9630529T SI 0858325 T1 SI0858325 T1 SI 0858325T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical formulation
dried pharmaceutical
stable freeze
freeze
stable
Prior art date
Application number
SI9630529T
Other languages
Slovenian (sl)
Inventor
Colette Batiment 5 BOULOUMIE
Thierry Breul
Laurence Colliere
Philippe Faure
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9513022A external-priority patent/FR2740686B1/en
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SI0858325T1 publication Critical patent/SI0858325T1/en

Links

SI9630529T 1995-11-03 1996-10-30 Stable freeze-dried pharmaceutical formulation SI0858325T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9513022A FR2740686B1 (en) 1995-11-03 1995-11-03 STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
EP96937367A EP0858325B1 (en) 1995-11-03 1996-10-30 Stable freeze-dried pharmaceutical formulation
PCT/FR1996/001706 WO1997017064A1 (en) 1995-11-03 1996-10-30 Stable freeze-dried pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SI0858325T1 true SI0858325T1 (en) 2003-02-28

Family

ID=26145038

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630529T SI0858325T1 (en) 1995-11-03 1996-10-30 Stable freeze-dried pharmaceutical formulation

Country Status (1)

Country Link
SI (1) SI0858325T1 (en)

Similar Documents

Publication Publication Date Title
HK1015697A1 (en) Stable freeze-dried pharmaceutical formulation
GB9519363D0 (en) Pharmaceutical formulation
EG23826A (en) Pharmaceutical formulations
GB9523752D0 (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
EP0862431A4 (en) Pharmaceutical formulation
ZA982872B (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB9523566D0 (en) Pharmaceutical formulation
ZA96526B (en) Novel pharmaceutical formulation
GB9709739D0 (en) Pharmaceutical formulation
HUP9900016A3 (en) Stable freeze-dried pharmaceutical formulation
ZA96392B (en) Pharmaceutical formulations
SI0858325T1 (en) Stable freeze-dried pharmaceutical formulation
AU5049098A (en) Pharmaceutical formulation
GB9500978D0 (en) Pharmaceutical formulations
GB9502786D0 (en) Pharmaceutical formulation
GB9525386D0 (en) Pharmaceutical formulation
GB9603141D0 (en) Pharmaceutical formulation
GB9503752D0 (en) Pharmaceutical formulations
GB9508989D0 (en) Pharmaceutical formulations
GB9516584D0 (en) Pharmaceutical formulations